Japan Pharmas Target Of GSK Merger Efforts To Make Global Drugs
This article was originally published in PharmAsia News
Executive Summary
Japan's drug market is being targeted by U.K.-based GlaxoSmithKline as a nation for linking up with other pharmas for global business efforts